VERTEX PHARMACEUTICALS INC / MA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
VERTEX PHARMACEUTICALS INC / MA has filed 3,637 SEC EDGAR filings since 15 Feb 1995

SEC filing history

Showing 501-525 of 1,000 matching filings.

Per page
25
Current page
21
4

FORM 4

Filing date
08 Feb 2024
Reporting date
06 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2024
Reporting date
06 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2024
Reporting date
06 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2024
Reporting date
06 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2024
Reporting date
06 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42126

SC 13G filing

Filing date
25 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jan 2024
Reporting date
08 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Dec 2023
Reporting date
15 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
15 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2023
Reporting date
05 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Dec 2023
Reporting date
05 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .